UK – Optis Cellular v. Apple Retail

Posted: October 7th, 2021

Optis Cellular v Apple Retail [2021] EWHC 2564 (Pat) In a lengthy and complex decision reaching over 80 pages, Mr Justice Meade has given judgment in the latest in a series of trials in the UK’s Patents Court between the claimants (“Optis”) and defendants (“Apple”) concerning Optis’ standard essential patents (SEPs) and the FRAND obligations […]


DE – Nokia v. Daimler

Posted: October 5th, 2020

Nokia v. Daimler, District Court of Mannheim, dec. of August 18, 2020, case docket 2 O 34/19 On August 18, 2020, the District Court of Mannheim handed down the first judgment in the current litigation campaign of Nokia v. Daimler. Despite Daimler’s FRAND defense, the Court enjoined Daimler from using a certain technology in Daimler […]


UK – TQ Delta, LLC v. ZyXEL Communications

Posted: April 11th, 2019

TQ Delta, LLC v ZyXEL Communications Limited & Anor [2019] EWHC 745 (Pat), 18 March 2019 In this judgment Mr Justice Carr granted an injunction against ZyXEL, following on from his earlier decision that TQ Delta’s EP (UK) 1,453,268 (“the 268 Patent”) was valid, essential and infringed. See our previous headnote here. ZyXEL submitted that […]


UK – Edwards Lifesciences v. Boston Scientific Scimed

Posted: June 8th, 2018

Edwards Lifesciences LLC v. Boston Scientific Scimed Inc, High Court of Justice, London, UK, 24 May 2018, [2018] EWHC 1256 (Pat) In this judgment of 24 May 2018, the latest in a saga during which the Court of Appeal had upheld an infringement decision of the Patents Court, Arnold J determined the details of a […]


UK – Regeneron v. Kymab and Novo Nordisk

Posted: June 4th, 2018

Regeneron Pharmaceuticals, Inc v Kymab Limited and Novo Nordisk A/S, UK Court of Appeal, 23 May 2018, [2018] EWCA 1186 (Civ) This is a judgment from the Court of Appeal on the appropriate form of order to be made following its finding that two of Regeneron’s patents are valid and infringed. At first instance, Henry […]